Barclays »

Aurinia Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6M 284k 8.99
2023-09-30 $993k 128k 7.77
2023-06-30 $485k 50k 9.68
2023-03-31 $746k 68k 10.97
2022-12-31 $279k 65k 4.31
2022-09-30 $4.9M 657k 7.52
2022-06-30 $11M 1.0M 10.05
2022-03-31 $5.5M 444k 12.38
2021-12-31 $14M 628k 22.87
2021-09-30 $13M 595k 22.13
2021-06-30 $2.5M 191k 13.25
2021-03-31 $5.5M 415k 13.25
2020-12-31 $2.2M 159k 13.80
2020-09-30 $3.3M 222k 14.73
2020-06-30 $1.3M 78k 16.23
2020-03-31 $1.1M 78k 14.50
2019-12-31 $2.3M 114k 20.26
2019-09-30 $1.1M 213k 5.35
2019-06-30 $4.0k 667 6.00
2019-03-31 $0 990 0.00
2018-12-31 $682k 100k 6.82
2018-09-30 $664k 100k 6.64
2018-06-30 $0 30 0.00
2018-03-31 $5.0k 1.0k 4.90
2017-09-30 $120k 19k 6.26
2017-06-30 $17k 2.8k 6.07